Relationship between the hippocampal shape abnormality and serum cortisol levels in first-episode and drug-naïve major depressive disorder patients
Depression and Anxiety2017Vol. 34(5), pp. 401–409
Citations Over TimeTop 19% of 2017 papers
Rieko Watanabe, Shingo Kakeda, Keita Watanabe, Xiaodan Liu, Asuka Katsuki, Wakako Umeno-Nakano, Hikaru Hori, Osamu Abe, Reiji Yoshimura, Yukunori Korogi
Abstract
The serum cortisol levels are therefore considered to be associated with hippocampal shape abnormalities in MDD.
Related Papers
- → S-adenosyl-methionine in depression: A comprehensive review of the literature(2003)97 cited
- → Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder(2023)4 cited
- → Stimulants augmentation with an antidepressant for the treatment of the major depressive disorder (MDD)(2019)
- → The association between polymorphism of norepinephrine transporter G1287A and major depressive disorder, antidepressant response: a meta-analysis(2020)
- → The risks and benefits of antidepressant use in patients with major depressive disorder (MDD) have been highlighted(2004)